Conversations on Today’s Priorities!
Experience innovation through collaboration and gain global stakeholder perspective with thought-provoking discussion on life sciences issues, worldwide. Each session below will be deconstructed by acclaimed panelists and feature open conversations on controversial topics.
DIAmond Sessions represent rare opportunities for deeper connection with regulatory leadership through insightful dialogue. Join us in Chicago, IL to help forge cohesive pathways and processes toward the interconnected future of global health.
FDA Town Hall
Courtney Granville, PhD, MPH, Global Associate Director, Research and Scientific Programs, DIA
EMA-FDA Question Time
Sabine Haubenreisser, PhD, MSc, , Principal Scientific Administrator, Stakeholders and Communication Division, European Medicines Agency, Netherlands
Katherine Tyner, PhD, FDA Liaison to the EMA, Office of Global Policy and Strategy, OC, FDA
Preparing for the Future of Research and Development:10-Years of Multistakeholder Innovation, Collaboration, and Transformation
Ania Mitan, Senior Vice President & Managing Director, DIA EMEA, India and Singapore
Leveraging Real-World Evidence to Address Diversity Gaps in Randomized Clinical Trials: Regulatory, Clinical, and Other Considerations
Nancy A. Dreyer, PhD, MPH, FISPE,Chief Scientific Officer & SVP, IQVIA